47 related articles for article (PubMed ID: 16617326)
1. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations.
De Re V; Sansonno D; Simula MP; Caggiari L; Gasparotto D; Fabris M; Tucci FA; Racanelli V; Talamini R; Campagnolo M; Geremia S; Dammacco F; De Vita S
Leukemia; 2006 Jun; 20(6):1145-54. PubMed ID: 16617326
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia.
Fornasieri A; Bernasconi P; Ribero ML; Sinico RA; Fasola M; Zhou J; Portera G; Tagger A; Gibelli A; D'amico G
Clin Exp Immunol; 2000 Dec; 122(3):400-3. PubMed ID: 11122246
[TBL] [Abstract][Full Text] [Related]
3. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia.
Charles ED; Green RM; Marukian S; Talal AH; Lake-Bakaar GV; Jacobson IM; Rice CM; Dustin LB
Blood; 2008 Feb; 111(3):1344-56. PubMed ID: 17942751
[TBL] [Abstract][Full Text] [Related]
4. Mixed Cryoglobulinaemia Vasculitis after Persistent Hepatitis C Virus Eradication.
Gaudêncio M; Nogueira R; Afonso N
Eur J Case Rep Intern Med; 2021; 8(8):002808. PubMed ID: 34527630
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and kidney involvement in human viral diseases caused by SARS-CoV-2, HIV, HCV and HBV.
da Mata GF; Fernandes DE; Luciano EP; Sales GTM; Riguetti MTP; Kirsztajn GM
J Venom Anim Toxins Incl Trop Dis; 2021; 27():e20200154. PubMed ID: 34381495
[TBL] [Abstract][Full Text] [Related]
6. Delineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus-induced cryoglobulinemia.
Ogishi M; Yotsuyanagi H; Moriya K; Koike K
Sci Rep; 2016 Jul; 6():29532. PubMed ID: 27403724
[TBL] [Abstract][Full Text] [Related]
7. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.
Dammacco F; Racanelli V; Russi S; Sansonno D
Clin Exp Med; 2016 Aug; 16(3):233-42. PubMed ID: 26935415
[TBL] [Abstract][Full Text] [Related]
8. Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia.
Russi S; Sansonno D; Mariggiò MA; Vinella A; Pavone F; Lauletta G; Sansonno S; Dammacco F
Arthritis Res Ther; 2014 Mar; 16(2):R73. PubMed ID: 24636026
[TBL] [Abstract][Full Text] [Related]
9. Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment.
Carbone A; Gloghini A
World J Gastroenterol; 2013 Nov; 19(44):7874-9. PubMed ID: 24307781
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile.
Minopetrou M; Hadziyannis E; Deutsch M; Tampaki M; Georgiadou A; Dimopoulou E; Vassilopoulos D; Koskinas J
Clin Vaccine Immunol; 2013 May; 20(5):698-703. PubMed ID: 23467778
[TBL] [Abstract][Full Text] [Related]
11. The hepatitis C virus infection as a systemic disease.
Zignego AL; Gragnani L; Giannini C; Laffi G
Intern Emerg Med; 2012 Oct; 7 Suppl 3():S201-8. PubMed ID: 23073858
[TBL] [Abstract][Full Text] [Related]
12. Molecular signature in HCV-positive lymphomas.
De Re V; Caggiari L; Garziera M; De Zorzi M; Repetto O
Clin Dev Immunol; 2012; 2012():623465. PubMed ID: 22952554
[TBL] [Abstract][Full Text] [Related]
13. HCV and lymphoproliferation.
Zignego AL; Giannini C; Gragnani L
Clin Dev Immunol; 2012; 2012():980942. PubMed ID: 22852020
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection and mixed cryoglobulinemia.
Lauletta G; Russi S; Conteduca V; Sansonno L
Clin Dev Immunol; 2012; 2012():502156. PubMed ID: 22844322
[TBL] [Abstract][Full Text] [Related]
15. HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.
Sautto G; Mancini N; Solforosi L; Diotti RA; Clementi M; Burioni R
Clin Dev Immunol; 2012; 2012():705013. PubMed ID: 22690241
[TBL] [Abstract][Full Text] [Related]
16. The role of humoral innate immunity in hepatitis C virus infection.
Tarr AW; Urbanowicz RA; Ball JK
Viruses; 2012 Jan; 4(1):1-27. PubMed ID: 22355450
[TBL] [Abstract][Full Text] [Related]
17. Molecular mimicry as a mechanism of autoimmune disease.
Cusick MF; Libbey JE; Fujinami RS
Clin Rev Allergy Immunol; 2012 Feb; 42(1):102-11. PubMed ID: 22095454
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.
Schamberg NJ; Lake-Bakaar GV
Gastroenterol Hepatol (N Y); 2007 Sep; 3(9):695-703. PubMed ID: 21960882
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection and lymphoma.
Bachy E; Besson C; Suarez F; Hermine O
Mediterr J Hematol Infect Dis; 2010 Mar; 2(1):e2010004. PubMed ID: 21415946
[TBL] [Abstract][Full Text] [Related]
20. PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.
Simula MP; Cannizzaro R; Canzonieri V; Pavan A; Maiero S; Toffoli G; De Re V
Mol Med; 2010; 16(5-6):199-209. PubMed ID: 20454521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
